P.Acnes Colony Count Following Subdermal Cefazolin

• Status: Unknown status
• Trial end date: 2020-04-01
• Target enrollment: 0
• Participant gender: All

Summary

The specific outcome is to determine whether the colony count of Propionibacterium acnes, one of the commonest causes of shoulder infection and not eradicated by conventional forms of surgical preparatory solutions and antibiotics, in a shoulder surgical wound will be altered by the use of subdermal cefazolin.

• Phase: Early Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: University of British Columbia
• Treatments: Cefazolin

Criteria

Inclusion Criteria:

• age greater than or equal to 18

• patients requiring deltopectoral approach and opening of joint capsule for primary shoulder surgery

Exclusion Criteria:

• allergy to cefazolin or cephalosporins

• tattoos over operative site

• previous surgical site infections in either shoulder

• revision surgical procedure

• immunocompromised patients